Cargando…
Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2
A key tenet of protection from infection for dentists is to know who is not infectious. The evidence base regarding protection from respiratory pathogens in dentistry is poor. Those with a positive SARS-CoV-2 IgG antibody are non-infectious (>99% certainty) and can be safely treated with good uni...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582419/ https://www.ncbi.nlm.nih.gov/pubmed/33097885 http://dx.doi.org/10.1038/s41415-020-2228-9 |
_version_ | 1783599187192971264 |
---|---|
author | Denning, David W. Kilcoyne, Anthony Ucer, Cemal |
author_facet | Denning, David W. Kilcoyne, Anthony Ucer, Cemal |
author_sort | Denning, David W. |
collection | PubMed |
description | A key tenet of protection from infection for dentists is to know who is not infectious. The evidence base regarding protection from respiratory pathogens in dentistry is poor. Those with a positive SARS-CoV-2 IgG antibody are non-infectious (>99% certainty) and can be safely treated with good universal precautions, even for aerosol generating procedures. Viral infectivity with SARS-CoV-2 lasts eight days, unlike viral polymerase chain reaction (PCR) swab tests which can persist for as long as seven weeks. SARS-CoV-2 IgG antibody becomes detectable from 11 days after infection. SARS-CoV-2 IgG antibodies are usually neutralising against the virus and their direct antiviral activity was partially demonstrated in 33,000 patients with COVID-19 treated with convalescent plasma in the USA. So, a positive SARS-CoV-2 IgG antibody is a much more accurate determination of infectiousness than a repeat PCR which is only 70% sensitive. It remains to be seen whether SARS-Cov-2 vaccine responses include protective IgG titres and, once vaccines become widespread, can be used to assist decision-making on appropriate personal protective equipment (PPE) in dentistry. |
format | Online Article Text |
id | pubmed-7582419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75824192020-10-23 Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 Denning, David W. Kilcoyne, Anthony Ucer, Cemal Br Dent J Opinion A key tenet of protection from infection for dentists is to know who is not infectious. The evidence base regarding protection from respiratory pathogens in dentistry is poor. Those with a positive SARS-CoV-2 IgG antibody are non-infectious (>99% certainty) and can be safely treated with good universal precautions, even for aerosol generating procedures. Viral infectivity with SARS-CoV-2 lasts eight days, unlike viral polymerase chain reaction (PCR) swab tests which can persist for as long as seven weeks. SARS-CoV-2 IgG antibody becomes detectable from 11 days after infection. SARS-CoV-2 IgG antibodies are usually neutralising against the virus and their direct antiviral activity was partially demonstrated in 33,000 patients with COVID-19 treated with convalescent plasma in the USA. So, a positive SARS-CoV-2 IgG antibody is a much more accurate determination of infectiousness than a repeat PCR which is only 70% sensitive. It remains to be seen whether SARS-Cov-2 vaccine responses include protective IgG titres and, once vaccines become widespread, can be used to assist decision-making on appropriate personal protective equipment (PPE) in dentistry. Nature Publishing Group UK 2020-10-23 2020 /pmc/articles/PMC7582419/ /pubmed/33097885 http://dx.doi.org/10.1038/s41415-020-2228-9 Text en © British Dental Association 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Opinion Denning, David W. Kilcoyne, Anthony Ucer, Cemal Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |
title | Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |
title_full | Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |
title_fullStr | Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |
title_full_unstemmed | Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |
title_short | Non-infectious status indicated by detectable IgG antibody to SARS-CoV-2 |
title_sort | non-infectious status indicated by detectable igg antibody to sars-cov-2 |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582419/ https://www.ncbi.nlm.nih.gov/pubmed/33097885 http://dx.doi.org/10.1038/s41415-020-2228-9 |
work_keys_str_mv | AT denningdavidw noninfectiousstatusindicatedbydetectableiggantibodytosarscov2 AT kilcoyneanthony noninfectiousstatusindicatedbydetectableiggantibodytosarscov2 AT ucercemal noninfectiousstatusindicatedbydetectableiggantibodytosarscov2 |